Author details

Full Name

Daniel E Cohen

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35240221	ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern.	Antiviral Res	2022
21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010
19480576	Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men.	Clinical Infectious Diseases	2009
18176318	Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center.	Journal of acquired immune deficiency syndromes (1999)	2008
17682938	Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection.	AIDS and Behavior	2008
18301057	Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity.	AIDS	2008
18373435	Immunological rebound after initiation of highly active antiretroviral therapy in treatment-naive patients.	AIDS Research and Human Retroviruses	2008
18283202	Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.	Annals of Internal Medicine	2008
18275276	Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.	J Infect Dis	2008
17116664	Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.	Antimicrobial Agents and Chemotherapy	2007
17428188	Urine-based asymptomatic urethral gonorrhea and chlamydia screening and sexual risk-taking behavior in men who have sex with men in greater Boston.	AIDS Patient Care and STDs	2007
17502229	Primary care issues for HIV-infected patients.	Infectious Disease Clinics of North America	2007
17389912	Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.	PLoS One	2007
17287271	Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.	J Virol	2007
16772368	T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.	Int Immunol	2006
16511771	Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection.	Clin Infect Dis	2006
16893325	Prevalence of hepatitis C virus infection among men who have sex with men at a Boston community health center and its association with markers of high-risk behavior.	AIDS Patient Care and STDs	2006
15059848	HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.	Blood	2004
15551204	Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.	Journal of Infectious Diseases	2004
15381726	Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.	J Exp Med	2004
15194783	Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.	J Virol	2004
15199314	HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.	AIDS	2004
15186531	Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasians.	AIDS Res Hum Retroviruses	2004
14963115	Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.	J Virol	2004
12802762	Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.	Clinical Infectious Diseases	2003
12525643	Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.	J Virol	2003
11915000	Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.	Clinical Infectious Diseases	2002
11360218	Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.	Clin Infect Dis	2001